Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Keith A Johnson

Showing results (371-380 of 392) with videos related to

Pageof 40
Sort By:
Brain Informatics|January 27, 2025
Rethinking the residual approach: leveraging statistical learning to operationalize cognitive resilience in Alzheimer's diseaseColin Birkenbihl, Madison Cuppels, Rory T Boyle, et al.
Medrxiv : the Preprint Server for Health Sciences|September 4, 2024
Rethinking the residual approach: Leveraging machine learning to operationalize cognitive resilience in Alzheimer's diseaseColin Birkenbihl, Madison Cuppels, Rory T Boyle, et al.
Plos One|September 21, 2016
Correction: Quantitative Amyloid Imaging in Autosomal Dominant Alzheimer's Disease: Results from the DIAN Study GroupYi Su, Tyler M Blazey, Christopher J Owen, et al.
Plos One|March 25, 2016
Quantitative Amyloid Imaging in Autosomal Dominant Alzheimer's Disease: Results from the DIAN Study GroupYi Su, Tyler M Blazey, Christopher J Owen, et al.
Medrxiv : the Preprint Server for Health Sciences|February 23, 2026
The prognostic value of blood-based p-tau217 levels on progression to clinical impairmentRachel F Buckley, Diana L Townsend, Colin J Birkenbihl, et al.
JAMA|July 15, 2026
Prognostic Value of Blood-Based P-Tau217 Levels for Progression to Cognitive ImpairmentRachel F Buckley, Diana L Townsend, Colin J Birkenbihl, et al.
The Lancet. Neurology|January 22, 2022
Variant-dependent heterogeneity in amyloid β burden in autosomal dominant Alzheimer's disease: cross-sectional and longitudinal analyses of an observational studyJasmeer P Chhatwal, Stephanie A Schultz, Eric McDade, et al.
Nature Medicine|November 6, 2019
Resistance to autosomal dominant Alzheimer's disease in an APOE3 Christchurch homozygote: a case reportJoseph F Arboleda-Velasquez, Francisco Lopera, Michael O'Hare, et al.
JAMA|June 16, 2025
Frequency and Clinical Outcomes Associated With Tau Positron Emission Tomography PositivityAlexis Moscoso, Fiona Heeman, Sheelakumari Raghavan, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 23, 2024
Harmonizing tau positron emission tomography in Alzheimer's disease: The CenTauR scale and the joint propagation modelAntoine Leuzy, Lars Lau Raket, Victor L Villemagne, et al.
Pageof 40

Showing results (371-380 of 392) with videos related to

Sort By:
Pageof 40
Brain Informatics|January 27, 2025
Rethinking the residual approach: leveraging statistical learning to operationalize cognitive resilience in Alzheimer's diseaseColin Birkenbihl, Madison Cuppels, Rory T Boyle, et al.
Medrxiv : the Preprint Server for Health Sciences|September 4, 2024
Rethinking the residual approach: Leveraging machine learning to operationalize cognitive resilience in Alzheimer's diseaseColin Birkenbihl, Madison Cuppels, Rory T Boyle, et al.
Plos One|September 21, 2016
Correction: Quantitative Amyloid Imaging in Autosomal Dominant Alzheimer's Disease: Results from the DIAN Study GroupYi Su, Tyler M Blazey, Christopher J Owen, et al.
Plos One|March 25, 2016
Quantitative Amyloid Imaging in Autosomal Dominant Alzheimer's Disease: Results from the DIAN Study GroupYi Su, Tyler M Blazey, Christopher J Owen, et al.
Medrxiv : the Preprint Server for Health Sciences|February 23, 2026
The prognostic value of blood-based p-tau217 levels on progression to clinical impairmentRachel F Buckley, Diana L Townsend, Colin J Birkenbihl, et al.
JAMA|July 15, 2026
Prognostic Value of Blood-Based P-Tau217 Levels for Progression to Cognitive ImpairmentRachel F Buckley, Diana L Townsend, Colin J Birkenbihl, et al.
The Lancet. Neurology|January 22, 2022
Variant-dependent heterogeneity in amyloid β burden in autosomal dominant Alzheimer's disease: cross-sectional and longitudinal analyses of an observational studyJasmeer P Chhatwal, Stephanie A Schultz, Eric McDade, et al.
Nature Medicine|November 6, 2019
Resistance to autosomal dominant Alzheimer's disease in an APOE3 Christchurch homozygote: a case reportJoseph F Arboleda-Velasquez, Francisco Lopera, Michael O'Hare, et al.
JAMA|June 16, 2025
Frequency and Clinical Outcomes Associated With Tau Positron Emission Tomography PositivityAlexis Moscoso, Fiona Heeman, Sheelakumari Raghavan, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 23, 2024
Harmonizing tau positron emission tomography in Alzheimer's disease: The CenTauR scale and the joint propagation modelAntoine Leuzy, Lars Lau Raket, Victor L Villemagne, et al.
Pageof 40